Complete response of advanced hepatocellular carcinoma to sorafenib: another case and a comprehensive review

Since sorafenib was introduced in 2007 for treating advanced hepatocellular carcinoma (HCC), 15 patients have achieved a complete response (CR) in advanced HCC. However, only four of these reports can be regarded as real CRs involving adequate assessments including imaging, serum tumor markers, and...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Clin Mol Hepatol
मुख्य लेखकों: Kim, Tae Suk, Kim, Ji Hoon, Kim, Baek hui, Lee, Young-Sun, Yoo, Yang Jae, Kang, Seong Hee, Suh, Sang-June, Jung, Young Kul, Seo, Yeon Seok, Yim, Hyung Joon, Yeon, Jong Eun, Byun, Kwan Soo
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: The Korean Association for the Study of the Liver 2017
विषय:
Case Report
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5760007/
https://ncbi.nlm.nih.gov/pubmed/28633200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2016.0070
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
लोड हो रहा है...

समान संसाधन